Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1

Journal of Neurotrauma

Volumn 26, Issue 11, 2009, Pages 1935-1941

  Tejima, Emiri ^a,b   Guo, Shuzhen ^a,b   Murata, Yoshihiro ^a,b   Arai, Ken ^a,b   Lok, Josephine ^a,b   Van Leyen, Klaus ^a,b   Rosell, Anna ^b   Wang, Xiaoying ^a,b   Lo, Eng H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood brain barrier; Neuroprotection; Neurovascular unit; Stroke; Traumatic brain injury

Indexed keywords

GELATINASE B; RECOMBINANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; STROKE; TRANSGENIC MOUSE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ANIMALS; BRAIN INJURIES; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HYPOXIA-ISCHEMIA, BRAIN; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; NEURONS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 75449117953     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.0959     Document Type: Article

References (49)

1. Adair, J.C., Charlie, J., Dencoff, J.E., Kaye, J.A., Quinn, J.F., Camicioli, R.M., Stetler-Stevenson, W.G., and Rosenberg, G.A. (2004). Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 35, e159-e162.
2. Aoki, T., Sumii, T., Mori, T., Wang, X., and Lo, E.H. (2002). Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33, 2711-2717.
3. Asahi, M., Asahi, K., Jung, J.C., del Zoppo, G.J., Fini, M.E., and Lo, E.H. (2000). Role of matrix metalloproteinase 9 in focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1690.
4. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J., Moskowitz, M.A., Fini, M.E., and Lo, E.H. (2001). Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732.
5. Asahina, M., Yoshiyama, Y., and Hattori, T. (2001). Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator inAlzheimer's disease brain. Clin. Neuropathol. 20, 60-63.
6. Baker, A.H., Sica, V., Work, L.M., Williams-Ignarro, S., de Nigris, F., Lerman, L.O., Casamassimi, A., Lanza, A., Schiano, C., Rienzo, M., Ignarro, L.J., and Napoli, C. (2007). Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 104, 3597-3602.
7. Candelario-Jalil, E., Yang, Y., and Rosenberg, G.A. (2009). Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158, 983-994.
8. Chirco, R., Liu, X.W., Jung, K.K., and Kim, H.R. (2006). Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 25, 99-113.
9. Falo, M.C., Fillmore, H.L., Reeves, T.M., and Phillips, L.L. (2006). Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J. Neurosci. Res. 84, 768-781.
10. Fujimoto, M., Takagi, Y., Aoki, T., Hayase, M., Marumo, T., Gomi, M., Nishimura, M., Kataoka, H., Hashimoto, N., and Nozaki, K. (2008). Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 28, 1674-1685.
11. Gardner, J., and Ghorpade, A. (2003). Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74, 801-806.
12. Gidday, J.M., Gasche, Y.G., Copin, J.C., Shah, A.R., Perez, R.S., Shapiro, S.D., Chan, P.H., and Park, T.S. (2005). Leukocytederived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is pro-inflammatory after transient focal cerebral ischemia. Am. J. Physiol. 289, H558-H568.
13. Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A.Y., and Lipton, S.A. (2005). A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25, 6401-6408.
14. Gu, Z., Kaul, M., Yan, B., Kridel, S.J., Cui, J., Strongin, A., Smith, J.W., Liddington, R.C., and Lipton, S.A. (2002). S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297, 1186-1190.
15. Guedez, L., McMarlin, A.J., Kingma, D.W., Bennett, T.A., Stetler-Stevenson, M., and Stetler-Stevenson, W.G. (2001). Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am. J. Pathol. 158, 1207-1215.
16. Jiang, X., Namura, S., and Nagata, I. (2001). Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci. Lett. 305, 41-44.
17. Jung, K.K., Liu, X.W., Chirco, R., Fridman, R., and Kim, H.R. (2006). Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J. 25, 3934-3942.
18. Kawasaki, Y., Xu, Z.Z., Wang, X., Park, J.Y., Zhuang, Z.Y., Tan, P.H., Gao, Y.J., Roy, K., Corfas, G., Lo, E.H., and Ji, R.R. (2008). Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 14, 31-336.
19. Kruger, A., Sanchez-Sweatman, O.H., Martin, D.C., Fata, J.E., Ho, A.T., Orr, F.W., Ruther, U., and Khokha, R. (1998). Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene 16, 2419-2423.
20. Lee, S., and Lo, E.H. (2004). Induction of caspase-mediated cell death by matrix metalloproteinase after hypoxia-reoxygenation in human brain microvscular endothelial cells. J. Cereb. Blood Flow Metab. 24, 720-727.
21. Lee, S.R., Kim, H.Y., Rogowska, J., Zhao, B.Q., Bhide, P., Parent, J.M., and Lo, E.H. (2006). Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci. 26, 3491-3495.
22. Lee, S.R., Tsuji, K., Lee, S., and Lo, E.H. (2004). Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J. Neurosci. 24, 671-678.
23. Liu, X.W., Bernardo, M.M., Fridman, R., and Kim, H.R. (2003). Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase= phosphatidylinositol 3-kinase and MAPK signaling pathway. J. Biol. Chem. 278, 40364-40372.
24. Lo, E.H. (2008). A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 14, 497-500.
25. Lorenzl, S., Albers, D.S., Relkin, N., Ngyuen, T., Hilgenberg, S.L., Chirichigno, J., Cudkowicz, M.E., and Beal, M.F. (2003). Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem. Int. 43, 191-196.
26. Magnoni, S., Baker, A., Thomson, S., Jordan, G., George, S.J., McColl, B.W., McCulloch, J., and Horsburgh, K. (2007). Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury. Gene Ther. 14, 621-625.
27. Montaner, J. (2006). Stroke biomarkers: can they help us to guide stroke thrombolysis? Drug News Perspect. 19, 523-532.
28. Mori, T., Wang, X., Jung, J., Sumii, T., Singhal, A.B., Fini, M.E., Dixon, C.E., Alessandrini, A., and Lo, E.H. (2002). Mitogen activated protein kinase inhibition for traumatic brain injury: in vitro and in vivo effects. J. Cereb. Blood Flow Metab. 22, 444-452.
29. Reeves, T.M., Prins, M.L., Zhu, J., Povlishock, J.T., and Phillips, L.L. (2003). Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J. Neurosci. 23, 10182-10189.
30. Romanic, A.M., White, R.F., Arleth, A.J., Ohlstein, E.H., and Barone, F.C. (1998). Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Stroke 29, 1020-1030.
31. Rosell, A., Ortega-Aznar, A., Alvarez-Sabin, J., Fernandez-Cadenas, I., Ribo, M., Molina, C.A., Lo, E.H., and Montaner, J. (2006). Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37, 1399-1406.
32. Rosenberg, G.A. (2002). Matrix metalloproteinases in neuroinflammation. Glia 39, 279-291.
33. Rosenberg, G.A., Cunningham, L.A., Wallace, J., Alexander, S., Estrada, E.Y., Grossetete, M., Razhagi, A., Miller, K., and Gearing, A. (2001a). Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893, 104-112.
34. Rosenberg, G.A., Sullivan, N., and Esiri, M.M. (2001b). White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 32, 1162-1168.
35. Sellner, J., and Leib, S.L. (2006). In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9=TIMP-1 ratio and increased collagen type IV degradation. Neurobiol. Dis. 21, 647-656.
36. Shigemori, Y., Katayama, Y., Mori, T., Maeda, T., and Kawamata, T. (2006). Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir. Suppl. 96, 130-133.
37. Stetler-Stevenson, W.G. (2008). Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal. 1, 6.
38. Sumii, T., and Lo, E.H. (2002). Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33, 831-836.
39. Tejima, E., Zhao, B.Q., Tsuji, K., Rosell, A., van Leyen, K., Gonzalez, R.G., Montaner, J., Wang, X., and Lo, E.H. (2007). Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J. Cereb. Blood Flow Metab. 27, 460-468.
40. Thirumangalakudi, L., Samany, P.G., Owoso, A., Wiskar, B., and Grammas, P. (2006). Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J. Alzheimers Dis. 10, 111-118.
41. Tsuji, K., Aoki, T., Tejima, E., Arai, K., Lee, S.R., Atochin, D.N., Huang, P.L., Wang, X., Montaner, J., and Lo, E.H. (2005). Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36, 1954-1959.
42. Wang, J., and Tsirka, S.E. (2005). Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral hemorrhage. Brain 128, 1622-1633.
43. Wang, L., Zhang, Z.G., Zhang, R.L., Gregg, S.R., Hozeska-Solgot, A., LeTourneau, Y., Wang, Y., and Chopp, M. (2006). Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci. 26, 5996-6003.
44. Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M.A., Dixon, C.E., Fini, M.E., and Lo, E.H. (2000). Effects of matrix metalloproteinase 9 gene knockout on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037-7043.
45. Waubant, E., Goodkin, D., Bostrom, A., Bacchetti, P., Hietpas, J., Lindberg, R., and Leppert, D. (2003). IFN-beta lowers MMP-9= TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology 60, 52-57.
46. Yong, V.W. (2005). Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931-944.
47. Yong, V.W., Power, C., Forsyth, P., and Edwards, D.R. (2001). Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511.
48. Zhao, B.Q., Tejima, E., and Lo, E.H. (2007). Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 38, 748-752.
49. Zhao, B.Q., Wang, S., Kim, H.Y., Storrie, H., Rosen, B.R., Mooney, D.J., Wang, X., and Lo, E.H. (2006). Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441-445.